Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Rapid Blood Test Allows for Earlier Detection of Pregnancy

By LabMedica International staff writers
Posted on 07 Sep 2015
Early detection of pregnancy is important for caregivers in order to avoid certain medications and procedures that could harm a fetus, but unfortunately, clinics are experiencing too many false-negative results from point-of-care urine-based tests.

An immunoassay used for the qualitative detection of human chorionic gonadotropin (hCG) in human whole blood, plasma or serum is now available and the test is used as an early detection aid for pregnancy for health care professionals in a variety of clinical and critical care settings.

The assay has now been Clinical Laboratory Improvement Amendments (CLIA) registered and classified by the US Food and Drug Administration (FDA; Silver Springs, MD, USA). More...
The new hCG test is the first single-step, capillary blood hCG test requiring no equipment to receive FDA 510(k) clearance. The hCG test can detect pregnancy approximately two to eight days earlier than commonly available urine-based tests. The hCG test results are available 10 minutes after the test is used.

The ADEXUSDx hCG Test is a from a product line manufactured by NOWDiagnostics Inc. (Springdale, AR, USA). The patented technology allows physicians to easily and accurately receive results within minutes by using a single drop of capillary or whole blood. Testing is a single-step process that can identify common conditions, illnesses and diseases with the same or better accuracy, sensitivity, specificity and precision as a predicate device in a full-scale laboratory. The diagnostic test kits can be processed in as little as 5 to 15 minutes, onsite in-clinic and by staff technicians and nurses.

Kevin Clark, CEO and president and of NOWDiagnostics Inc., said, “It's too important for the safety of the mother and fetus to not have accurate pregnancy results in our emergency rooms and clinics. Our hCG test can save lives and reduce liability for health care providers. We see a great opportunity to save hospitals and clinics time, money and resources by providing them a lab in the palm of their hands.”

Related Links:

US Food and Drug Administration
NOWDiagnostics Inc. 



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Manual Pipetting Aid
Pipette Controllers macro
Electrolyte Analyzer
BKE-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.